Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Towards a mechanistic understanding of response to SBRT by patients with borderline resectable pancreatic cancer

ABSTRACT: Towards a mechanistic understanding of response to SBRT by patients with borderline resectable pancreatic cancer

PROVIDER: PRJNA937327 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23578900.fastq.gz	Fastqsanger.gz
	SRR23578901.fastq.gz	Fastqsanger.gz
	SRR23578847.fastq.gz	Fastqsanger.gz
	SRR23578848.fastq.gz	Fastqsanger.gz
	SRR23578849.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 55

Similar Datasets

Towards a mechanistic understanding of response to SBRT by patients with borderline resectable pancreatic cancer

Project description:Five year survival rates for pancreatic cancer remain low, around 11%. We assessed differential gene expression between SBRT responders and non-responders as well as expression pre and post SBRT. Samples were obtained from the University of Colorado biorepository. All patients had borderline resectable pancreatic cancer, treated with neoadjuvant chemotherapy followed by restaging, and treatment with 30–33.6 Gy SBRT to pancreatic tumors, followed by pancreaticoduodenectomy and adjuvant chemotherapy. We observed increases in PDL1, PD1, CD25, and a decrease in CD122 expression following RT. Furthermore, we found that responders to SBRT exhibit decrased CD25 expression with increased CD122 and CD132 expression compared to non-responders. Using GSEA of responders vs. non-responders, we found responders to SBRT exhibit enrichment of inflammatory response, IFN signaling, and IL2/STAT5 signaling.

2023-04-20 | GSE225767 | GEO

Towards a Genomic Understanding of Myeloma

Project description:Towards a Genomic Understanding of Myeloma

| PRJNA75317 | ENA

Towards an Understanding of the Pathomechanisms of Uterine Fibroids

Project description:Towards an Understanding of the Pathomechanisms of Uterine Fibroids

| PRJNA821713 | ENA

PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES

Project description:Capecitabine, oxaliplatin, irinotecan and bevacizumab as perioperative strategy of borderline and/or high risk resectable colorectal cancer liver metastases

| 2162638 | ecrin-mdr-crc

Single cell multiomics guided mechanistic understanding of Fontan-associated liver disease

Project description:Single cell multiomics guided mechanistic understanding of Fontan-associated liver disease

| PRJNA928662 | ENA

Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency

Project description:Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency

| PRJNA615185 | ENA

Salivary microRNAs May Be A Valuable Biomarker To Detect Resectable Pancreatic Cancer

Project description:Early surgery is vital in the treatment of highly fatal pancreatic cancer (PC). But there is no valuable and non-invasive biomarker to screen PC currently. Studies showed many salivary molecules can detect several systemic diseases. We aimed to investigate whether salivary microRNAs (miRNAs) can act as a biomarker to detect resectable PC. By Agilent microarray salivary miRNAs were profiled from saliva samples from 8 patients with resectable PC and 8 healthy controls. Candidate biomarkers discovered from the profile were subjected to validation by qPCR.

2013-12-15 | E-GEOD-53325 | biostudies-arrayexpress

Molecular pathway analysis towards understanding tissue vulnerability in spinocerebellar ataxia type 1

Project description:Molecular pathway analysis towards understanding tissue vulnerability in spinocerebellar ataxia type 1

| PRJNA503578 | ENA

Towards a mechanistic understanding of patient response to neoadjuvant SBRT with anti-PDL1 in human HPV-unrelated locally advanced HNSCC: Phase I/Ib trial results

Project description:Towards a mechanistic understanding of patient response to neoadjuvant SBRT with anti-PDL1 in human HPV-unrelated locally advanced HNSCC: Phase I/Ib trial results

| PRJNA865104 | ENA

Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis

Project description:Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis

| PRJNA539874 | ENA